US-based Gilead Sciences` remdesivir, a potential antiviral drug to treat COVID-19 patients and is under several trials around the world, has reportedly failed to produce desired results during a Chinese trial study, the Financial Times reported on Thursday.
More than 27 lakh people have been infected by the coronavirus COVID-19 world wide with the death toll crossing 1.9 lakh, the virus which first emerged in China in December 2019 could be the start of World War 3 and the world would not even know. The analysis was done by Zee News Editor-in-Chief Sudhir Chaudhary in DNA, the world's most-watched news show.
